hmpl-306,amdizalisib
hutchmed
['cml', 'hmpl-306', 'lymphoma', 'hutchmed', 'dizal']
new and updated clinical data of hmpl-306 and amdizalisib will be presented at the european hematology association annual meeting #eha2023 and the 17th international conference on malignant lymphoma #icml. 
HUTCHMED ($HCM) is an innovative biopharmaceutical company which researches, develops, manufactures and markets pharmaceutical products.